Related Experiment Video
Updated: May 2, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
09:58
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
6.5K
Crossed cerebellar hypermetabolism demonstrated by FDG PET
1From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Clinical Nuclear Medicine
|February 26, 2014
Summary
Crossed cerebellar hypermetabolism, a rare finding on 18F-FDG PET scans, was observed in a patient with subclinical seizures. This hypermetabolism resolved after successful seizure control, suggesting a link between seizure activity and cerebellar metabolism.
Area of Science:
- Neuroimaging
- Nuclear Medicine
- Epileptology
Background:
- 18F-FDG PET is a crucial tool for localizing epileptogenic zones.
- Crossed cerebellar hypometabolism is a known phenomenon in epilepsy.
- Crossed cerebellar hypermetabolism is an infrequently reported finding.
Observation:
- A middle-aged woman presented with subclinical seizures detected via video electroencephalography.
- FDG PET imaging was performed to identify the seizure focus.
- The imaging revealed an unusual finding of crossed cerebellar hypermetabolism.
Findings:
- The observed crossed cerebellar hypermetabolism was transient.
- Metabolic activity in the cerebellum returned to normal after the patient's subclinical seizures were effectively managed.
- This suggests a direct correlation between seizure activity and cerebellar metabolic changes.
Implications:
- This case highlights a rare metabolic pattern in the cerebellum associated with seizure activity.
- It expands the understanding of FDG PET findings in epilepsy.
- Further research may elucidate the mechanisms underlying crossed cerebellar hypermetabolism in seizure disorders.
Related Concept Videos
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853

